Hereditary Central Nervous System Demyelinating Diseases: Clinical Trials

124 trials for Hereditary Central Nervous System Demyelinating Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

46 completed, 21 recruiting, 13 terminated, 13 withdrawn. 37 Phase 2, 25 Phase 1, 20 Not applicable, 11 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 237Completed 19, Terminated 5, Withdrawn 5, Active not recruiting 2, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Suspended 1, Unknown 1
Phase 125Completed 11, Withdrawn 4, Recruiting 3, Terminated 2, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Suspended 1
Not applicable20Completed 10, Not yet recruiting 3, Recruiting 3, Unknown 3, Terminated 1
Phase 311Completed 7, Active not recruiting 2, Terminated 2
Phase 41Active not recruiting 1

Follow Hereditary Central Nervous System Demyelinating Diseases: new trials by email Literature Review of Hereditary Central Nervous System Demyelinating Diseases trials Research Report on Hereditary Central Nervous System Demyelinating Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD
Lentiviral TYF-ARSA correction of patient's autologous HSCs - Metachromatic Leukodystrophy (MLD)
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-06-012026-09-01
IT and IV Lentiviral Gene Therapy for X-ALD
Intrathecal and intravenous LV gene therapy - X-linked Adrenoleukodystrophy
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute302027-06-012026-09-01
Direct Lentiviral Injection Gene Therapy for MLD
Intrathecal and intravenous LV gene therapy - Metachromatic Leukodystrophy (MLD)
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-05-312026-09-01
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)
PLX-200 - Lysosomal Storage Disorders, Sandhoff Disease
Phase 2Not yet recruitingPolaryx Therapeutics, Inc.242026-12-012026-07-31
Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
Spinal cord stimulation - Adrenomyeloneuropathy Without Cerebral Involvement
Not applicableRecruitingThird Military Medical University102025-02-102025-01-28
Mesh-Free Versus Mesh-Based Surgery for Female Stress Urinary Incontinence: A Prospective Comparison of Pubo-Urethral Ligament Plication and Transobturator Tape
Pubo-Urethral Ligament Plication (PLP), Transobturator Tape (TOT) - Stress Urinary Incontinence (SUI)
Not applicableRecruitingMehmet Incebıyik1472025-01-132025-12-18
Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients
FBX-101 - Krabbe Disease
TerminatedForge Biologics, Inc22024-08-062025-09-05
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
ION356 - Pelizaeus-Merzbacher Disease
Phase 1RecruitingIonis Pharmaceuticals, Inc.242024-04-102025-12-12
A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel
No Intervention - Cerebral Adrenoleukodystrophy (CALD)
RecruitingGenetix Biotherapeutics Inc.1202024-03-272025-07-02
Disease Progression in Women With X-linked Adrenoleukodystrophy
X-linked Adrenoleukodystrophy
RecruitingMinoryx Therapeutics, S.L.402024-01-022024-01-31
A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain
No Intervention - Metachromatic Leukodystrophy (MLD)
WithdrawnTakeda2023-11-302024-01-12
Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
PXL065 - ALD (Adrenoleukodystrophy)
Phase 2WithdrawnPoxel SA2023-09-012024-12-16
Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
PXL770 - Adrenomyeloneuropathy
Phase 2WithdrawnPoxel SA2023-09-012024-12-16
Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy
brainQuant module of brainTale-care platform - X-linked Adrenoleukodystrophy
Not yet recruitingAssistance Publique - Hôpitaux de Paris2002023-09-012023-07-03
Registry of X-linked Adrenoleukodystrophy
X-linked Adrenoleukodystrophy
RecruitingBeijing Tiantan Hospital2002023-07-202023-07-11
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Pramipexole, Placebo - Adrenoleukodystrophy, Restless Legs Syndrome
Phase 4Active not recruitingMassachusetts General Hospital242023-04-012026-07-01
Home Exercise for Individuals With Neurodegenerative Disease
Home exercise - Neurodegenerative Diseases, Leukodystrophy
Not applicableRecruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.302023-02-132026-09-16
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
FBX-101 - Krabbe Disease
Phase 1 / Phase 2Active not recruitingForge Biologics, Inc92023-02-032025-11-20
A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)
SBT101 Treatment - AMN, AMN Gene Mutation
Phase 1 / Phase 2TerminatedSwanBio Therapeutics, Inc.92022-11-172026-08-26
Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease
Pelizaeus-Merzbacher Disease
RecruitingIonis Pharmaceuticals, Inc.322022-10-032026-10-02

Showing 20 of 124. Sign in to see all of them.

Narrower conditions

Adrenoleukodystrophy (62)  ·  Leukodystrophy, Metachromatic (49)  ·  Leukodystrophy, Globoid Cell (31)  ·  Mucopolysaccharidosis I (17)  ·  Metabolism, Inborn Errors (16)  ·  Canavan Disease (13)  ·  Lysosomal Storage Diseases (13)  ·  Peroxisomal Disorders (13)  ·  Rare Diseases (13)  ·  Sphingolipidoses (12)  ·  Pelizaeus-Merzbacher Disease (11)  ·  Mucopolysaccharidosis II (10)  ·  Mucopolysaccharidosis VI (10)  ·  Leukoencephalopathies (9)  ·  Tay-Sachs Disease (9)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (124)  ·  Nutritional and Metabolic Diseases (124)  ·  Brain Diseases (122)  ·  Brain Diseases, Metabolic (121)  ·  Nervous System Diseases (120)  ·  Central Nervous System Diseases (119)  ·  Brain Diseases, Metabolic, Inborn (118)  ·  Genetic Diseases, Inborn (118)  ·  Demyelinating Diseases (117)  ·  Metabolic Diseases (117)  ·  Leukoencephalopathies (115)  ·  Metabolism, Inborn Errors (108)  ·  Heredodegenerative Disorders, Nervous System (80)  ·  Genetic Diseases, X-Linked (72)

Interventions

Stem Cell Transplantation (6)  ·  Alemtuzumab (5)  ·  Busulfan (3)  ·  Cyclophosphamide (3)  ·  Lorenzo's oil (3)  ·  Melphalan (3)  ·  trierucate (3)  ·  Bone Marrow Transplantation (2)  ·  Cholic Acid (2)  ·  Clofarabine (2)  ·  Cyclosporine (2)  ·  Exercise (2)  ·  GC 1 compound (2)  ·  Hematopoietic Stem Cell Transplantation (2)  ·  Hydroxyurea (2)

Sponsors

Masonic Cancer Center, University of Minnesota (8)  ·  Shire (8)  ·  Assistance Publique - Hôpitaux de Paris (5)  ·  Genetix Biotherapeutics Inc. (5)  ·  Ionis Pharmaceuticals, Inc. (4)  ·  Children's Hospital of Philadelphia (3)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (3)  ·  Joanne Kurtzberg, MD (3)  ·  Orchard Therapeutics (3)  ·  Pujol, Aurora, M.D. (3)  ·  Shenzhen Geno-Immune Medical Institute (3)  ·  Talaris Therapeutics Inc. (3)  ·  University of Pittsburgh (3)  ·  Aspa Therapeutics (2)  ·  Forge Biologics, Inc (2)

Countries

United States (72)  ·  Germany (18)  ·  France (17)  ·  Netherlands (13)  ·  Italy (12)  ·  United Kingdom (10)  ·  Australia (7)  ·  China (7)  ·  Spain (7)  ·  Argentina (6)  ·  Canada (6)  ·  Denmark (6)  ·  Israel (6)  ·  Japan (6)  ·  Brazil (5)

Top investigators

Paul Orchard, MD (6)  ·  Joanne Kurtzberg, MD (5)  ·  Patrick Aubourg, MD, PhD (3)  ·  Stephen Huhn, MD (3)  ·  Adeline Vanderver, MD (2)  ·  Caroline Sevin, MD, PhD (2)  ·  Florian Eichler, MD (2)  ·  Gerald V Raymond, M.D. (2)  ·  John Henderson, MD (2)  ·  Paul Szabolcs, MD (2)  ·  Suzanne T Ildstad, MD (2)  ·  Adrian Thrasher, MD, PhD (1)

Results publications

PMID 21586746, PMID 33332761, PMID 39383458, PMID 36196048, PMID 39383459, PMID 40267426, PMID 11231629, PMID 11399225, PMID 12064356, PMID 15784740, PMID 16002461, PMID 16194720, PMID 19833552, PMID 19892975, PMID 21474353, PMID 22911730, PMID 23845948, PMID 23966770, PMID 25487283, PMID 25758611, PMID 26000324, PMID 27289174, PMID 28644367, PMID 28976817, PMID 31077039, PMID 31214256, PMID 31315600, PMID 32342562, PMID 32634238, PMID 32749716, PMID 32750127, PMID 32792226, PMID 34781360, PMID 35065785, PMID 35142618, PMID 35333110, PMID 35778568, PMID 36681445, PMID 37782421, PMID 37920915, PMID 39499628, PMID 40957959, PMID 41030609, PMID 41667276

NIH funding

2018 (2), 2008 (1), 2015 (1), 2017 (1), 2019 (1), K23NS087151 (1), R01HD073292 (1), R01HD104814 (1), R01NS061965 (1), U01NS106845 (1), U54NS065768 (1), U54NS115052 (1)